Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
Randomized Controlled Trial
. 2014 Jun 9;348:g3617.
doi: 10.1136/bmj.g3617.

Effect of Screening and Lifestyle Counselling on Incidence of Ischaemic Heart Disease in General Population: Inter99 Randomised Trial

Affiliations
Free PMC article
Randomized Controlled Trial

Effect of Screening and Lifestyle Counselling on Incidence of Ischaemic Heart Disease in General Population: Inter99 Randomised Trial

Torben Jørgensen et al. BMJ. .
Free PMC article

Abstract

Objective: To investigate the effect of systematic screening for risk factors for ischaemic heart disease followed by repeated lifestyle counselling on the 10 year development of ischaemic heart disease at a population level.

Design: Randomised controlled community based trial.

Setting: Suburbs of Copenhagen, Denmark.

Participants: 59,616 people aged 30-60 years randomised with different age and sex randomisation ratios to an intervention group (n = 11,629) and a control group (n = 47,987).

Intervention: The intervention group was invited for screening, risk assessment, and lifestyle counselling up to four times over a five year period. All participants with an unhealthy lifestyle had individually tailored lifestyle counselling at all visits (at baseline and after one and three years); those at high risk of ischaemic heart disease, according to predefined criteria, were furthermore offered six sessions of group based lifestyle counselling on smoking cessation, diet, and physical activity. After five years all were invited for a final counselling session. Participants were referred to their general practitioner for medical treatment, if relevant. The control group was not invited for screening.

Main outcome measures: The primary outcome measure was incidence of ischaemic heart disease in the intervention group compared with the control group. Secondary outcome measures were stroke, combined events (ischaemic heart disease, stroke, or both), and mortality.

Results: 6091 (52.4%) people in the intervention group participated at baseline. Among 5978 people eligible at five year follow-up (59 died and 54 emigrated), 4028 (67.4%) attended. A total of 3163 people died in the 10 year follow-up period. Among 58,308 without a history of ischaemic heart disease at baseline, 2782 developed ischaemic heart disease. Among 58,940 without a history of stroke at baseline, 1726 developed stroke. No significant difference was seen between the intervention and control groups in the primary end point (hazard ratio for ischaemic heart disease 1.03, 95% confidence interval 0.94 to 1.13) or in the secondary endpoints (stroke 0.98, 0.87 to 1.11; combined endpoint 1.01, 0.93 to 1.09; total mortality 1.00, 0.91 to 1.09).

Conclusion: A community based, individually tailored intervention programme with screening for risk of ischaemic heart disease and repeated lifestyle intervention over five years had no effect on ischaemic heart disease, stroke, or mortality at the population level after 10 years.Trial registration Clinical trials NCT00289237.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work other than those listed above; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None
Fig 1 Flow chart of randomised Inter99 study showing distribution and participation of 59 616 people in various groups during four contacts (baseline, one year, three years, and five years) over five year period. IHD=ischaemic heart disease. *59 993 people were drawn for study population, but 377 emigrated, died, changed their personal identification number, or disappeared before baseline, leaving 59 616. †Random sample of control group (n=5264) received questionnaires. ‡1308 people were randomly allocated to low intensity intervention group; this intervention group was only used to investigate whether lower intensity intervention was effective to achieve changes in lifestyle (described in detail in appendix 1); this group is not included in endpoint analyses, as power calculations were based on large high intensity intervention group, as shown in this figure (for fuller flow chart including low intensity intervention group see www.Inter99.dk)
None
Fig 2 Cumulative incidence curves of 10 year incidence of ischaemic heart disease (IHD), stroke, combined events (IHD, stroke, or both), and total mortality in intervention and control groups

Comment in

Similar articles

See all similar articles

Cited by 64 articles

See all "Cited by" articles

References

    1. World Health Organization. European health report: health and health systems. WHO, 2009.
    1. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8. - PubMed
    1. Hjermann I, Holme I, Leren P. Oslo Study Diet and Antismoking Trial: results after 102 months. Am J Med 1986;80:7-11. - PubMed
    1. Ebrahim S, Davey Smith G. A systematic review and meta-analysis of randomised controlled trials of health promotion for prevention of coronary heart disease in adults. BMJ 1997;314:1666-74. - PMC - PubMed
    1. Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial. JAMA 1990;263:1795-801. - PubMed

Publication types

Associated data

Feedback